Takeshi Takahashi
Direttore/Membro del Consiglio presso Pathalys Pharma, Inc.
Posizioni attive di Takeshi Takahashi
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Pathalys Pharma, Inc.
 Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Takeshi Takahashi
Precedenti posizioni note di Takeshi Takahashi
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/05/2020 | 12/09/2023 |
| Independent Dir/Board Member | 01/05/2020 | 12/09/2023 | |
| TSUGAMI CORPORATION | Direttore operativo | 01/04/2020 | - |
| Direttore Tecnico/Scientifico/R&S | 01/04/2020 | - | |
| Corporate Officer/Principal | - | 01/04/2020 |
Formazione di Takeshi Takahashi
| Waseda University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Giappone | 3 |
Posizioni
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Producer Manufacturing | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| TSUGAMI CORPORATION | Producer Manufacturing |
| Aziende private | 1 |
|---|---|
Pathalys Pharma, Inc.
Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | Health Technology |
- Borsa valori
- Insiders
- Takeshi Takahashi
- Esperienza
